Clinical Trials Directory

Trials / Terminated

TerminatedNCT01240954

Comparison of Different Up-dosing Schedules With Osiris

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
210 (estimated)
Sponsor
ALK-Abelló A/S · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare different up-dosing schedules with Osiris.

Conditions

Interventions

TypeNameDescription
DRUGOSIRISOSIRIS current practice
DRUGOSIRIS other concentration 1OSIRIS new concentration 1
DRUGOSIRIS other concentration 2OSIRIS new concentration 2

Timeline

Start date
2010-12-01
First posted
2010-11-15
Last updated
2011-08-29

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT01240954. Inclusion in this directory is not an endorsement.